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With increasing life span and prevalence of dementia, it is important to understand the 
mechanisms of cognitive ageing. Here, we focus on a subgroup of the population we term 
“cognitively frail”, defined by reduced cognitive function in the absence of subjective memory 
complaints, or a clinical diagnosis of dementia. Cognitive frailty is distinct from cognitive 
impairment caused by physical frailty. It has been proposed to be a precursor to Alzheimer’s 
disease, but may alternatively represent one end of a non-pathological spectrum of cognitive 
aging. We test these hypotheses in humans of both sexes, by comparing the structural and 
neurophysiological properties of a community-based cohort of cognitive frail adults, to people 
presenting clinically with diagnoses of Alzheimer’s disease or mild cognitive impairment, and 
community-based cognitively typical older adults. Cognitive performance of the cognitively frail 
was similar to those with mild cognitive impairment. We used a novel cross-modal paired-
associates task that presented images followed by sounds, to induce physiological responses of 
novelty and associative mismatch, recorded by EEG/MEG. Both controls and cognitively frail 
showed stronger mismatch responses and larger temporal grey matter volume, compared to 
people with mild cognitive impairment and Alzheimer’s disease. Our results suggest that 
community-based cognitively frail represents a spectrum of normal ageing rather than incipient 
Alzheimer’s disease, despite similar cognitive function. Lower lifelong cognitive reserve, hearing 
impairment and cardiovascular comorbidities might contribute to the aetiology of the cognitive 
frailty. Critically, community-based cohorts of older adults with low cognitive performance should 
not be interpreted as representing undiagnosed Alzheimer’s disease.   
 
Significance statement 
The current study investigates the neural signatures of cognitive frailty in relation to healthy 
ageing and Alzheimer’s disease. We focus on the cognitive aspect of frailty and show that despite 
performing similarly to the patients with mild cognitive impairment, a cohort of community-
based adults with poor cognitive performance do not show structural atrophy or 
neurophysiological signatures of Alzheimer’s disease. Our results call for caution before assuming 
that cognitive frailty represents latent Alzheimer’s disease. Instead the cognitive 
underperformance of cognitively frail adults could may a result of cumulative effects of multiple 
psychosocial risk factors over the lifespan, and medical comorbidities.  
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With longer life span and an older population, there is a pressing need to understand the 
mechanisms that determine cognitive ageing, and its relationship to dementias. The cognitively 
frail, is a population of interest, defined by reduced cognitive function in the absence of 
subjective memory complaints, or a clinical diagnosis of dementia, mild cognitive impairment 
(MCI) or other pre-existing neurological explanation. Here cognitive frailty does not refer only to 
the cognitive impairments of those with comorbid physical frailty (Kelaiditi et al., 2013). Cognitive 
frailty has been linked to a higher risk of dementia, and is often regarded as a precursor to 
Alzheimer’s disease (Panza et al., 2006; Buchman et al., 2007; Kojima et al., 2016; Shimada et al., 
2018). In the absence of physical frailty, cognitive impairment alone is associated with 
longitudinal decline in functional abilities, activities of daily living (Shimada et al., 2016), increased 
hospitalisation and all-cause mortality rate (Avila-Funes et al., 2012; Solfrizzi et al., 2012; Ge et 
al., 2020).  
However, there is an alternative hypothesis: poor cognitive performance reflects adverse aspects 
of normal ageing, without latent Alzheimer’s disease or other neurodegenerative process. 
Psychosocial, educational, medical factors may contribute to cognitive frailty in the absence of 
latent degenerative or vascular dementia pathologies. For example cognitively under-performing 
adults are four times more likely to come from disadvantaged socioeconomic backgrounds, and 
twice as likely to have lower educational qualifications (Rogers et al., 2017). They are more likely 
to be malnourished (Mulero et al., 2011; Talegawkar et al., 2012; Chye et al., 2018), sedentary 
lifestyle (Landi et al., 2010; Rogers et al., 2017), have more medical comorbidities such as 
cardiovascular disease (Patrick et al., 2002; Langlois et al., 2012; Fuhrmann et al., 2019), chronic 
inflammation (Walston et al., 2002; Weaver et al., 2002; Cappola et al., 2003) and hearing 
impairment (Valentijn et al., 2005; Panza et al., 2015). 
Here we determine whether cognitively frail community dwelling older adults have structural 
and/or neurophysiological characteristics of normal ageing or early Alzheimer’s disease. We 
quantify brain structure and function using magnetic resonance imaging (MRI) and electro-
magnetoencephalography (E/MEG) respectively. In Alzheimer’s disease, amyloid plaques and 
neurofibrillary tangles form early in entorhinal cortex and hippocampi (Hardy and Selkoe, 2002; 
Braak et al., 2006), leading to disruptions in synaptic and neural function (LaFerla and Oddo, 
2005; West and Bhugra, 2015) and atrophy. If the cognitively frail have prodromal or 
undiagnosed Alzheimer’s disease pathology, one would expect similar structural and 
neurophysiological changes. To assess the neural systems of hippocampal-dependent associative 
memory, we designed the cross-modal oddball task. The trials consisted of repeated pairings of 
an abstract image with a sound. A mismatch response arose from pairs that included either a 
novel sound (i.e. novelty deviant), or a sound that was not novel, but had been previously 
associated with a different image (i.e. associative deviant). The novelty deviants are akin to 
typical mismatch negativity responses; proposed to be an index of auditory predictive coding, 
which is attenuated in Alzheimer’s disease (Ruzzoli et al., 2016; Laptinskaya et al., 2018). The 
associative deviants are a more sensitive test of Alzheimer’s disease, since hippocampal 
dysfunction would impair the ability to establish cross-modal associations (Gottfried and Dolan, 
2003; Joassin et al., 2011), and attenuate the response to associative deviants. Indeed, previous 
studies report impaired performance on the paired-associates learning task (PAL) in MCI and 
preclinical Alzheimer’s disease, which correlates with disease progression (Blackwell et al., 2004; 
Ahmed et al., 2008). Moreover, in fMRI PAL shows Alzheimer’s-related increased hippocampal 
activity and connectivity between hippocampus and cortical areas, (de Rover et al., 2011; 
Harrison et al., 2016). We measured novelty and associative deviant responses in lateral 
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frontotemporal areas, readily detected by E/MEG in auditory oddball paradigms and reduced in 
dementia (Pekkonen, 2000; Garrido et al., 2009; Phillips et al., 2016).  
We proposed that if cognitively frailty represents part of the spectrum of normal ageing, rather 
than latent Alzheimer’s disease, then the neurophysiological responses and structural features of 
cognitively frail adults would resemble cognitively healthy adults rather than the patients with 
MCI or Alzheimer’s disease.  
 
Materials and Methods 
Study design  
The Cam-CAN Frail Project is an extension of the large-scale cross-sectional population-based 
Cambridge Centre for Ageing and Neuroscience study (Cam-CAN (Shafto et al., 2014)), focused 
on cognitive frailty. It examines the sub-population of community-dwelling adults with cognitive 
frailty, identified from home screening visits by cognitive screening tests: below 25/30 on the 
MMSE and/or below 88/100 on the ACER in the absence of a diagnosis or referral for a memory 
disorder.  
The Cam-CAN Frail protocol comprised of three sessions. First, a visit to the participant’s home to 
assess lifestyle, health and cognitive performance on an extensive neuropsychological test 
battery. The battery included the revised Addenbrooke’s Cognitive Examination (ACER), Mini 
Mental State Examination (MMSE), Wechsler Adult Intelligence Scale logical memory test, Spot 
the Word test, simple choice reaction time, famous faces test, four-mountains task, virtual object 
location and orientation, Rey figure recall, and the trail making test. In the second session, 
participants underwent E/MEG scanning and completed the Cattell and digit symbol tests. During 
the E/MEG recording, participants completed the cross-modal oddball task. In the final session, 
participants had a functional and structural magnetic resonance imaging and completed the 
Hotel task. The study was approved by the East of England – Cambridge Central Research Ethics 
Committee (10/H0308/50).  
 
Participants 
Participants consisted of community-dwelling older healthy controls, and patients diagnosed with 
either MCI or Alzheimer’s disease by secondary healthcare services (Table 1). The cognitively frail 
individuals were defined by underperformance on cognitive tests, without any subjective 
memory complaints or clinical diagnosis of dementia, MCI or other significant neurological and 
psychiatric illness. A control group of cognitively successful healthy older adults was recruited, 
from the participants who had been assessed at home as part of the Cam-CAN 3000 home 
assessment (Shafto et al., 2014), but who had not been recruited into the “Cam-CAN 700” or 
“Cam-CAN 280” re-assessments. These healthy cognitive controls scored >25/30 on MMSE or 
>88/100 on the ACER during the home interview. The Cam-CAN home visits acquired lifestyle and 
cardiovascular risk characteristics (alcohol and smoking, hypertension, history of stroke and heart 
attack).  
In addition, patients were recruited from local specialist memory clinics who had MCI or probable 
Alzheimer’s disease diagnosed according to Petersen and McKhann criteria respectively 
(McKhann et al., 2011; Petersen et al., 2014). Most MCI/AD patients had positive cerebrospinal 
fluid biomarker status for Alzheimer’s disease pathology, or clinical follow up to confirm the 
diagnosis. Participants were recruited from either sex, and were older than 50 years and were 
fluent speakers in English, with mental capacity to consent. Participants did not have any 
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significant psychiatric illness or established neurological condition (other than MCI or Alzheimer’s 
disease in the patient groups). 
 
E/MEG and MRI acquisition 
We used E/MEG to quantify neurophysiological dysfunction , as used in studies of healthy 
successful aging (Vlahou et al., 2014; Tsvetanov et al., 2015; Coquelet et al., 2017; Price et al., 
2017), and early signatures of MCI and Alzheimer’s disease (Osipova et al., 2005; Stam et al., 
2006; de Haan et al., 2012; Maestú et al., 2015; Hughes et al., 2019; Kocagoncu et al., 2020). 
E/MEG data were acquired using the Elekta Vector View system with 204 planar gradiometers 
and 102 magnetometers. Simultaneous EEG data were acquired using a 70-channel Easycap. 
Participants’ horizontal and vertical eye movements, and the cardiac activity were recorded using 
bipolar electro-oculogram and electro-cardiogram electrodes. Five head position indicator coils 
were placed on the EEG cap, to track the head position every 200 ms. For coregistration of the 
participant’s T1-weighted MRI scan to the MEG sensors, three fiducial points (nasion, left and 
right pre-auricular) and a minimum of 100 head shape points were digitized using Polhemus 
digitization.  
Participants were seated in a magnetically shielded room (IMEDCO) and positioned under the 
MEG scanner. Auditory stimuli were delivered binaurally through MEG-compatible ER3A insert 
earphones (Etymotic Research). The delay in sound delivery due to the length of earphone tubes 
and sound card was 26 ± 2 ms on average. Visual stimuli were presented on the screen 
positioned 1.22 m in front of the participant’s visual field. Simultaneous E/MEG was recorded 
continuously at 1000 Hz with a high-pass filter of 0.03 Hz. Before the E/MEG recording, 
participants performed an automated hearing test in the MEG scanner, to make sure that the 
earphones were working properly. They were presented pure tones at the frequency of 1000 Hz 
to either ear with varying loudness. Participants were instructed to press the button when they 
heard the tone. The mean hearing levels of each group is given in Table 1, where the normal 
range is expected to fall within 45-75 dB.  
T1-weighted structural images were acquired on a Siemens 3T Magnetom Prisma MRI Scanner 
using a MPRAGE sequence (repetition time = 2250ms, echo time = 2.99ms; inversion time = 
900ms; flip angle = 9 degrees; field of view = 256mm x 240mm x 192mm; voxel size = 1mm 
isotropic; GRAPPA acceleration factor = 2; acquisition time = 4 minutes 32 seconds). Four 
participants did not tolerate MRI due to claustrophobia.  
 
Stimuli 
The stimuli consisted of abstract images and pure tones. There were four images with distinct 
patterns. The tones had the following frequencies: 503 Hz, 719 Hz, 1021 Hz and 1451 Hz. 
Harmonic tones were avoided by choosing frequencies of prime numbers and varying them by at 
least 3 semi-tones. There were four types of trials. 1) Standard (STD) trials were image-tone pairs 
that participants trained on prior to the task. Standard pairs were the trials presented most 
frequently. 2) Associative deviant (DA) trials presented the same images of the standard pairs but 
by shuffling the sounds. The DA trials were expected to capture the binding effect arising from a 
mismatch in association. 3) Novelty deviant (DN) trials presented the standard images with rare 
deviant tones. The frequencies used for the novel deviants were 599 Hz, 857 Hz, 1017 Hz, 1733 
Hz. The DN trials were expected to capture the novelty effect, and were essentially the deviants 
used in conventional mismatch paradigms. The deviant trials were expected to induce a 
mismatch response with respect to the response to standard trials. 4) Target trials: The standard 
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pairs, where the image was bound by a red circle. Target trials were included to make sure 
participants were attending to the stimuli. There were in total of 1000 standard trials and 
associative deviant, novel deviant and target trials were presented 48 times each. Therefore, the 
associative deviant, novel deviant and the targets were each encountered 4% of the time each, 
whereas standards 88% of the time. 
 
Paradigm 
The cross-modal oddball paradigm depends on both change detection and associative binding. 
This has two advantages. First, as MEG recording has lower signal to noise ratio in the subcortical 
areas and deeper sources compared to signal coming from superficial cortices (Goldenholz et al., 
2009), the task was specifically designed to capture the indirect response in the superior 
temporal gyri and inferior frontal gyri, that are dependent on hippocampal associative learning. 
Secondly, the integrity of the auditory and frontal cortex is preserved until late stages of 
Alzheimer’s disease, allowing us to control for atrophy of the cortical generators of the mismatch 
response. The task was easy to perform both by all participant groups, require minimal training 
(reducing potential confounds such as education and cognitive strategies on performance).  
Images were presented centrally on a grey screen bounded by a black circle for 800 ms. Then, 
300 ms after image onset, the tone was played for 500 ms (Figure 1A). The 300 ms lag was 
introduced to allow participants to form predictions about the upcoming auditory stimuli. In 
between trials, a black fixation square was presented for a jittered period of 300-500 ms, 
resulting in a stimulus onset asynchrony between 1000-1200 ms. E-Prime 2 (Psychology Software 
Tools) was used to present the stimuli and send triggers to the scanner. 
In the training phase, participants were presented in total four images and four tones (i.e. 
standard pairs), 25 times each, and were instructed to try to remember the pairings between the 
images and the tones. After the training, participants performed a short test where they listened 
to the four tones twice in a randomised order. After each tone, they were shown four images (i.e. 
chance level of %25) on the screen and were asked to select the image that was paired with that 
tone. Irrespective of the participant’s performance, training was repeated only once. Following 
the training participants moved on to the main task. Trials were presented in a different 
randomised order for each participant across four 5-minute long blocks. Participants were 
instructed to pay attention to the images and press the button with their right index finger when 
the image was bound by a red circle.  
 
E/MEG pre-processing and source localization 
The raw E/MEG data were pre-processed using MaxFilter 2.2.12 (Elekta Oy). Maxfiltering 
included detection and interpolation of bad sensors, signal space separation to remove external 
noise from the data and head movement correction. Cardiac and blink artefacts were detected 
and removed using an independent component analysis with 800 maximum steps and 64 
principal components via the EEGLAB toolbox (Delorme and Makeig, 2004). The independent 
component time series were correlated with EOG and ECG time series and spatial templates. The 
components that revealed higher than z=3 in the temporal and z=2 in the spatial dimension were 
removed and the remaining time series of the independent components were reconstructed. On 
average 2.38 blink components (SD = 0.58) and 1.30 cardiac components (SD = 0.49) were 
removed.  
Data were further processed in SPM12 (www.fil.ion.ucl.ac.uk/spm). Data were bandpass filtered 
between 0-40 Hz using a fifth-order Butterworth filter. The continuous data were epoched 
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between -100 to 500 ms from the sound onset. OSL’s artefact rejection algorithm 
(github.com/OHBA-analysis/osl-core) was used to remove remaining artefacts (e.g. motor). Bad 
channels and trials marked by the algorithm were removed. On average 53.04 (4.6 %; SD = 35.88) 
trials and 10.76 channels (2.8 %; SD = 5.85) were removed per participant. Trials were averaged 
within condition, using robust averaging. Low-pass filter was re-applied to correct for the high-
frequency noise introduced by robust averaging. 
The E/MEG data were source localised using all sensor data: magnetometers, gradiometers and 
EEG (Henson et al., 2009). The source space was modelled with a medium sized cortical mesh 
consisting of 8196 vertices via inverse normalization of SPM’s canonical meshes. Sensor positions 
were coregistered to the native T1-weighted MPRAGE scans using the fiducial and head shape 
points after removing digitisation points around the nose. SPM’s canonical template brain was 
used for participants who did not tolerate the MRI scan. Single shell and Boundary Element 
models were used for forward modelling of MEG and EEG data respectively. Evoked signal was 
estimated over the trials using the COH solution in SPM which imposes spatial smoothness on the 
prior covariance matrix. All inversion accuracies were above 80%, as measured by the proportion 
of variance explained in the sensor data (M = 93.62; SD = 3.63).  
Although neurophysiological responses in the hippocampus are difficult to detect with E/MEG, 
owing to its depth, a strong mismatch response can be recorded from temporal cortex, where 
sensory predictions are assumed to be established from hippocampal-dependent cross-modal 
associative learning. We therefore focus on the mismatch response in the lateral temporal 
auditory and frontal cortex, as activated in conventional auditory oddball paradigms (Pekkonen, 
2000; Garrido et al., 2009; Hughes and Rowe, 2013; Phillips et al., 2016; Hughes et al., 2018). The 
source localised data were extracted from 6 areas taken from the Automated Anatomical 
Labelling atlas: Heschl’s gyri, superior temporal gyri and inferior frontal gyri bilaterally (Figure 2C). 
The ROI masks were resliced to 1mm isotropic thickness to allow maximum data extraction. For 
each participant and condition, the data were extracted from the peak within all the vertices that 
constitute each ROI. This is to maximise the signal to noise ratio in the data, and to account for 
individual variability in source activity. We had two contrasts of interest in the analyses: the STD-
DN contrast captures the novelty mismatch effect, while the STD-DA contrast captures the 
associative mismatch effect.  
 
MRI pre-processing and grey matter analysis 
The T1 image was rigid-body co-registered to a Montreal Neurological Institute (MNI) template 
and then corrected for image inhomogeneity and segmented into 6 tissue classes (grey matter, 
white matter, cerebrospinal fluid, bone, soft tissue, and residual noise) using SPM’s unified 
segmentation algorithm (Ashburner and Friston, 2005). The native space grey and white matter 
images for all participants were then submitted to diffeomorphic registration (DARTEL) 
(Ashburner, 2007) to create group template images. The group template was then normalised to 
the MNI template via an affine transformation and the combined normalisation parameters 
(native to group template and group template to MNI template) were applied to each individual 
participant’s grey matter image, including modulation in order to preserve local volume. Region 
of Interest (ROI) from the Harvard-Oxford atlas were then used to extract mean regional GMV 
from the bilateral hippocampal and entorhinal ROIs for each participant. The GMVs were 
compared across groups using ANCOVAs where age and total intracranial volume (TIV) were set 
as covariates.  
To calculate local grey matter atrophy at the whole brain level we used voxel-based 
morphometry (VBM). Grey matter segments were thresholded with an absolute masking level of 
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0.1, and were smoothed with a Gaussian kernel at 8 mm full width half maximum. Grey matter 
volumes were compared across groups in pairwise t-contrasts in general linear models 
accounting for differences in age and total intracranial volume. The cluster level p-values were 
corrected for multiple comparisons using the family-wise error after a cluster defining threshold 
of p < 0.05. 
 
RMS and statistical analyses 
To investigate differences in time series, the root-mean-square of the time series at each ROI and 
trial were smoothed using a moving average at every 50 time points, to remove jumps. The RMS 
at each time point was then modelled using general linear models (GLM) accounting for 
differences in age and hearing levels, and tested for within group task effects by using t-
contrasts. The contrasts compared the signal intensity between the DA-STD and DN-STD. The 
tests comparing the deviant effects were performed firstly within each participant group, to 
reveal task-specific effects. Secondly, these differences were tested across groups to test for 
interaction effects between conditions and groups. The observed cluster masses in the GLMs 
were corrected for multiple comparisons using permutation cluster statistics, by bootstrapping 
the design matrix using 1000 permutations at p = 0.05. The mean of the time series within each 
contrast were calculated for each participant within the 200-500 ms time window after removing 
outliers. This time window was selected because task effects were strongest after the N100. The 
linear relationship between these metrics and predictor variables were further tested through 
general linear models across the sample including age as a covariate, and after removing outliers. 
The predictors of interest were years of education, ACER total and memory subscale scores, and 
hippocampal and entorhinal grey matter volumes. 
 
Results 
Sample characteristics  
Sample characteristics and scores on neuropsychological tests were compared across the groups 
using ANOVAs. Age (F(3,87) = 3.82; p = 0.012) and years of education (F(3,87) = 11.34; p < 0.001) 
differed between groups. Tukey’s HSD tests showed that the cognitively frail group was older 
than controls (p = 0.006). The duration of formal education was longer in those in the control 
group than the cognitively frail (p < 0.001), and Alzheimer’s disease group (p = 0.032). The MCI 
group had had longer education than the cognitively frail (p < 0.001) and Alzheimer’s disease (p = 
0.001) groups. Hearing levels were tested for group differences using both ANOVA and ANCOVA 
(to control for differences in age). There were no significant differences in hearing in the left ear. 
In the right ear there was a group difference (F(3,86) = 4.70; p = 0.004): the hearing of the 
cognitively frail was lower than control (p = 0.017) and MCI (p = 0.005) groups. When adjusting 
for the differences in age (F(3,85) = 3.02; p = 0.034), the hearing levels on the right were still 
lower in the cognitively frail group compared to the MCI group (p = 0.019). Chi-square tests 
compared the prevalence of lifestyle and cardiovascular risk factors between control and the 
cognitively frail groups. The prevalence of daily alcohol consumption was lower in the cognitively 
frail group (19%) compared to controls (43%) (X2(1) = 6.11; p = 0.006). The prevalence of 
hypertension was higher in the cognitively frail group (52%) compared to the controls (35%) 
(X2(1) = 2.74; p = 0.048). There were no significant differences between groups in the prevalence 
of smoking, history of stroke or heart attack. 
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Cognitive results  
Cognitive scores were tested for group differences after controlling for differences in age (Table 
1). The MMSE (F(3,86) = 17.64; p < 0.001), ACER total score (F(3,86) = 55.41; p < 0.001), ACER’s 
subscales in memory (F(3,86) = 37.35; p < 0.001), attention (F(3,86) = 9.05; p < 0.001), fluency 
(F(3,86) = 13.87; p < 0.001), language (F(3,86) = 7.90; p < 0.001) and visuospatial skills (F(3,86) = 
11.15; p < 0.001) showed strong differences across the groups (Figure 1A). Results of the pairwise 
post-hoc comparisons are given in Figure 1B. The cognitively frail group performed similarly to 
the MCI group across all cognitive tests, except for the fluency subscale, where their scores were 
significantly lower than the MCI group (p < 0.001). All four groups performed above chance level 
on the training test. The scores were significantly different across groups (F(3,86) = 5.60; p = 
0.001). Post-hoc comparisons showed that the controls performed significantly better than the 
MCI (p = 0.015) and Alzheimer’s disease (p = 0.006) groups. There were no significant differences 
between the training scores of the cognitively frail group and other groups. 
 
Grey matter atrophy 
Mean hippocampal GMV, entorhinal GMV, total GMV and total intracranial volume (TIV) were 
compared across the groups, corrected for age and TIV using ANCOVA. There were no significant 
differences between groups for TIV or total GMV. However, hippocampal (F(3,86) = 10.35; p < 
0.001) and entorhinal (F(3,86) = 7.62; p < 0.001) GMVs showed a main group effect (Figure 2A-B). 
The hippocampal GMV in the control group was significantly larger compared to the MCI (p < 
0.001) and Alzheimer’s disease groups (p < 0.001). Similarly, the entorhinal GMV of the control 
group was larger compared to the MCI (p = 0.001) and Alzheimer’s disease groups (p = 0.003). 




Atrophy was tested at the voxel level, using VBM (Table 2). As expected, the control group had 
significantly higher GMV in bilateral temporal cortices and hippocampi compared to the MCI and 
AD. We found a similar pattern comparing cognitively frail group to MCI and Alzheimer’s disease 
group, although cluster extents were smaller (Figure 2D-E). In order to confirm that the 
differences we observe in the neurophysiological responses could be due to local GM atrophy of 
the lateral frontotemporal areas, we tested the GMV of the lateral frontotemporal areas 
bilaterally (i.e. IFG, STG, HG), and report that the GMVs of the superficial areas do not differ 
across groups (Extended data, Figure 2-1). 
 
Cross-modal mismatch responses 
Figure 3A-D displays the gradiometer topoplots for each condition in 100 ms time windows 
across the groups. Following N100, topoplots show a strong burst of bilateral activity in frontal 
and temporal sensors that is sustained until the end of the epoch. Note that compared to the 
associative deviant and standard, novelty deviant induced a stronger and more widespread 
activity across the frontotemporal sensors. The gradiometer topoplots are given here for 
visualisation only; statistical comparisons were made in the a priori source space ROIs. 
We tested the time series of each deviant with respect to the standard, within the 6 ROIs (Table 
3, Figure 3E). We found strongest effects for the novelty deviant in the bilateral IFG early in the 
epoch, following the onset of the sound. The effects seen in the cognitively frail group mirrored 
the controls. Further, novelty deviant effects were found across all the ROIs in the control group. 
COGNITIVE UNDERFORMANCE vs ALZHEIMER’S DISEASE 
11 
 
MCI and Alzheimer’s disease groups showed no significant novelty effects in the IFG, and weaker 
clusters limited to STG and HG. Associative deviant effects were found in the IFG across all 
groups, and in overlapping time windows starting around 200 ms after the sound onset.  
We tested for the interaction effects between the deviant responses (i.e. STD-DA, and STD-DN) 
and group. There was no significant interaction between the control and cognitively frail group or 
between MCI and Alzheimer’s disease groups. However, the control group showed stronger 
associative and novelty deviant responses compared to both MCI and Alzheimer’s disease groups. 
Similarly, cognitively frail group showed the same interaction effects against the MCI and 
Alzheimer’s disease groups. As a confirmatory analysis, we also repeated these GLMs with log-
transformed squared RMS time series to ensure that the normality assumption is met. These 
results can be found in the Extended data, Table 3-1.  
 
Clinical and structural correlates of the cross-modal mismatch 
To assess how the deviant responses relate to clinical severity, education and medial temporal 
lobe atrophy, the linear relationships between the E/MEG contrast means at 200-500 ms and 
each predictor variable were tested using general linear models (Figure 4A) whilst controlling for 
differences in age. This revealed strong relationships between the novelty deviant mean in the 
LHG and RHG with ACER total and ACER-memory subscale scores: the higher the scores on 
cognitive tests, the more negative (towards normal) the novelty deviant was. A strong negative 
relationship between the hippocampal and entorhinal volumes and the deviant response was 
observed for the left hemisphere ROIs, particularly the LHG. This suggests that medial temporal 
atrophy is associated with a reduced deviant response even though the MMN response arises 
from extra-hippocampal auditory cortex. This negative relationship was stronger for the novelty 
deviant compared to the associative deviant. Education showed moderate positive relationships 
with the associative deviant in the LSTG and RSTG, whereas it showed a negative relationship 
with the novelty deviant mean in RIFG.  
We calculated the partial correlations amongst predictor variables correcting for differences in 
age. Education showed positive correlations with ACER total (r = 0.40; p < 0.001) and ACER 
memory subscale scores (r = 0.35; p = 0.001), but did not correlate with hippocampal and 
entorhinal volumes. ACER total score correlated with both hippocampal (r = 0.53; p < 0.001) and 
entorhinal GMV (r = 0.40; p < 0.001). Similarly, ACER memory subscale score positively correlated 
with hippocampal (r = 0.55; p < 0.001) and entorhinal GMV (r = 0.41; p < 0.001).  
 
Discussion 
The principal result of this study is that community-dwelling cognitively frail individuals do not 
resemble people with MCI or Alzheimer’s disease, in terms of their structural or 
neurophysiological profile, despite similar levels of underperformance on cognitive screening 
tests. The poor cognitive performance of the cognitively frail participants should not simply be 
interpreted arising from latent Alzheimer pathology or undiagnosed amnestic MCI. Population 
screening using standard cognitive tests (e.g. MMSE, or ACER) is therefore unlikely to selectively 
identify those with latent Alzheimer’s disease pathology without additional biomarker evidence 
of pathology. There are other associations of cognitive impairment, including lower educational 
level, hearing impairment, and cardiovascular risk factors. Both structural and neurophysiological 
features of the cognitively frail group were similar to controls. Structural analyses revealed a 
higher GMV in the latero-medial temporal cortices bilaterally in the control and cognitively frail 
compared to MCI and Alzheimer’s disease groups. Like the controls, the cognitively frail showed 
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stronger associative and novelty deviant responses compared to MCI or Alzheimer’s disease in 
relation to hippocampal and entorhinal volumes. 
The cross-modal oddball task was designed to induce deviant responses from the superficial 
frontotemporal cortex, as neurophysiological markers of hippocampal-dependent associative 
learning. Alzheimer’s patients show impairments in both sensory and associative memory, 
reduced medial temporal lobe activity to novelty (Sperling et al., 2003; Dickerson et al., 2005), 
and reduced electrophysiological response to oddballs (Engeland et al., 2002; Lee et al., 2013; 
Ruzzoli et al., 2016). We confirmed that Alzheimer’s patients show reduced novelty and 
associative deviant responses. Neurophysiological profiles of the control and cognitively frail 
overlapped, and were significantly stronger compared to MCI and Alzheimer’s disease groups. 
Task effects of the novelty deviant responses were observed across all regions of interest for the 
control and cognitively frail. The group-task interaction effects showing stronger associative and 
novelty deviant responses for the controls and cognitively frail were located in right Heschl’s, 
bilateral superior temporal and inferior frontal gyri. In other words, the neuropsychologically 
impaired cognitively frail group does not show the neurophysiological signatures of early 
Alzheimer’s disease. From a theoretical perspective, it is interesting to note that the response 
associated with associative deviants was weaker than novelty deviants, and did not differ 
qualitatively in terms of timing or distribution across our ROIs. We had expected the associative 
deviant response to be more hippocampal-dependent, and hence more impaired with 
Alzheimer’s pathology, but our current analyses suggest it was qualitatively similar to the more 
typical novelty deviant response. 
To explore the differences between the community-based cognitively frail and Alzheimer’s 
disease or MCI, we tested volumetric differences in medial temporal lobe. Structurally, early 
Alzheimer’s disease is characterised by atrophy in the medial temporal lobe as a function of tau 
burden (Braak et al., 2006; Schwarz et al., 2016). Recent studies of cognitive frailty have 
suggested frontotemporal and subcortical atrophy (Del Brutto et al., 2017; Gallucci et al., 2018), 
increased white matter hyperintensities (Avila-Funes et al., 2017; Del Brutto et al., 2017; 
Sugimoto et al., 2019), and decreased white matter microstructure integrity (Avila-Funes et al., 
2017). We did not find structural differences between the control and cognitively frail in medial 
temporal lobe structures. The community-based groups showed significantly larger hippocampus 
and entorhinal volumes compared to patients with MCI and Alzheimer’s disease, and did not 
show early structural signatures of Alzheimer’s disease. The difference between our study and 
the previous work may lie in the epidemiological approach to baseline recruitment through the 
Cam-CAN 3000 cohort, rather than clinical referral pathways.  
The neuropsychological profile of the cognitively frail resembled MCI group. They scored lower 
than the healthy controls on every ACER subscale. Compared to the MCI patients, they were 
more impaired on fluency, which might indicate an underlying executive deficit. Previous studies 
have suggested that the neuropsychological profile of cognitive frailty differs from MCI in 
episodic memory with domains of language, visuospatial skills and executive function relatively 
spared (Collie and Maruff, 2000). The cognitive impairment profile in frail adults has been 
described in terms of deficits in executive function and attention. Frail adults tend to not use 
cues effectively to retrieve stored information (Canevelli et al., 2015; Delrieu et al., 2016); have 
slower reaction times (O'Halloran et al., 2014; Robertson et al., 2014), show lower meta-cognitive 
awareness, and error monitoring (Amanzio et al., 2017).  
However, many previous studies have focused on cognitive impairment in the context of physical 
frailty, rather than defining cognitive frailty in terms of poor cognitive function in a non-clinical 
community-dwelling cohort. The cognitive underperformance of our cognitively frail, might partly 
be attributed to their shorter education, coupled with a bias in most cognitive tests towards the 
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better educated (Huppert et al., 2005). That is, highly educated individuals perform better on 
cognitive tests like MMSE and ACER, unless scores are normalised by education (Crane et al., 
2006; Mathuranath et al., 2007; Amaral-Carvalho and Caramelli, 2012).  
Our findings support the hypothesis that cognitive frailty represents part of the spectrum of 
normal neurocognitive function, rather than incipient Alzheimer’s disease. This conclusion calls 
for a re-evaluation of the prior findings that associate cognitive frailty with higher incidence of 
dementia and faster cognitive decline (Buchman et al., 2007; Kojima et al., 2016; Shimada et al., 
2018). These former studies have quantified the dementia incidence including all subtypes of 
dementia, however this association was highest in non-Alzheimer’s dementias, particularly for 
vascular dementia (Panza et al., 2006; Avila-Funes et al., 2012; Gray et al., 2013; Aguilar-Navarro 
et al., 2016; Solfrizzi et al., 2017a). Although the link between cognitive frailty and Alzheimer’s 
disease in previous studies is not conclusive, the two entities might share common risk factors 
such as cardiovascular disease (Panza et al., 2006; Frisoli et al., 2015; Fuhrmann et al., 2019) and 
hearing impairment (Valentijn et al., 2005; Panza et al., 2015).  
In addition to the cardiovascular risk factors (Newman et al., 2001; Patrick et al., 2002; Fuhrmann 
et al., 2019), the cognitive underperformance of our cognitively frail group could be a result of 
cumulative effects of multiple psychosocial and medical risk factors. Malnutrition (Mulero et al., 
2011; Chye et al., 2018; Rietman et al., 2018), social isolation (Robertson et al., 2013), sedentary 
lifestyle (Landi et al., 2010), lack of intellectual cognitive activities (Jung et al., 2010), psychiatric 
illnesses and long term use of antidepressants (Paulson and Lichtenberg, 2013; Gray et al., 2015), 
chronic inflammation (Weaver et al., 2002; Solfrizzi et al., 2017b) and lower education levels 
(Rogers et al., 2017) are known risk factors affecting healthy ageing. Here, the cognitively frail 
group had significantly lower education levels, compared to the controls and MCI. This is a 
common pattern observed in other frailty studies (Brigola et al., 2019; Margioti et al., 2020). The 
cognitively frail population have significantly lower occurrence of third-level education 
(Robertson et al., 2014), and are twice as likely to have no educational qualifications (Rogers et 
al., 2017). Further, strong association between educational level and frailty was linked to 
mediating socioeconomic, behavioural, and psychosocial factors such as low income, chronic 
diseases, obesity, depression, unhealthy lifestyle, and chronic stress (Hoogendijk et al., 2014). 
This is consistent with the cognitive reserve hypothesis that an individual’s prior education and 
cognitive abilities modify the resilience of brain structure to disease and injury (Stern, 2002). 
Longer education in early life and continuing diverse cognitive leisure activities in midlife and old 
age contribute to an individual’s cognitive reserve, is related to better cognitive functioning in old 
age (Singh-Manoux et al., 2011; Borgeest et al., 2018; Lavrencic et al., 2018; Brigola et al., 2019) 
and having fewer symptoms of cognitive decline and neuropathology (Mortimer et al., 2003; 
Chapko et al., 2018).  
The study has several limitations. Due to the cross-sectional design of the study we are unable to 
quantify the rates of progression or conversion to dementia from cognitive frailty. Longitudinal 
cognitive and neuroimaging studies would be useful to confirm the rate of conversion to 
Alzheimer’s disease or other dementia, and potential mediators of conversion. Further, this study 
did not incorporate Alzheimer’s disease biomarkers and instead used clinical criteria and 
neuropsychological criteria to define the groups. The cognitively frail group was defined using a 
standard threshold on ACER and MMSE. Future studies investigating the link between cognitive 
frailty and Alzheimer’s disease may test for biomarkers of Alzheimer’s such as tau and amyloid-
beta measures acquired from blood, cerebrospinal fluid or positron emission tomography. Future 
studies may also assess the polygenic risk for Alzheimer’s disease using common (e.g. APOE) and 
rare variants associated with the disease, which would help disentangle environmental and 
psychosocial risk factors from genetic risk factors contributing to cognitive frailty’s aetiology. 
COGNITIVE UNDERFORMANCE vs ALZHEIMER’S DISEASE 
14 
 
Further work is needed to clarify genetic and pathology-based features of cognitive frailty in 
relation to Alzheimer’s disease and other dementias.  
Our findings provide new evidence that community-dwelling cognitively frail older adults are 
neurophysiologically and structurally similar to those with more successful cognitive ageing, 
without the structural or neurophysiological features of MCI or Alzheimer’s disease, despite 
similarly poor cognitive function to MCI. Their underperformance on cognitive tests may be due 
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Figures and captions 
 
Figure 1. A. The radar chart displays the group means for the neuropsychological tests converted to percentages 
against the maximum score in each test for ease of comparison across groups. Note that the performance of the 
cognitively frail group overlaps with the MCI across all tests except for ACER fluency.  B. Group differences in 
education levels and neuropsychological tests. The cognitively frail group had lower education levels than the 
controls. On the neuropsychological tests, the cognitively frail performed similar to the MCI group. C. Example 
stimuli from the cross-modal oddball task. The images were presented together with paired sounds after the 
300 ms lag. Participants were asked to press the button whenever they saw a red circle around the image. MCI: 
Symptomatic mild cognitive impairment after secondary/tertiary memory clinic assessment.  




Figure 2. A-B. GMV differences across groups in the hippocampus and entorhinal cortex. The boxplots display 
the normalised residuals after correcting for differences in age and total intracranial volume (TIV). There were 
no significant differences in volume between the cognitively frail and the control group. C. 6 ROIs used in the 
RMS analysis. ROIs comprise inferior frontal gyri (IFG), superior temporal gyri (STG) and Heschl’s gyri (HG) 
bilaterally. D-E. The contrast images from the VBM analysis. Control and the cognitively frail show similar 
patterns of grey matter volume compared to the MCI and Alzheimer’s disease groups. See the Extended data 
for the grey matter volume analysis of the lateral frontotemporal ROIs used in the RMS analysis (Figure 2-1). 
MCI: Symptomatic mild cognitive impairment after secondary/tertiary memory clinic assessment.  




Figure 2-1: Grey matter volume analysis of the lateral frontotemporal network. In Alzheimer’s disease. atrophy 
of the auditory cortex comes at the later isocortical Braak stages (ie V-VI) along with other neocortical areas 
such as the frontal cortex. Therefore, in the early stages of Alzheimer’s disease, the integrity of the auditory 
cortex is not expected to be compromised, and consequently, diminished deviant responses observed in our 
clinical population are not expected be attributed to the atrophied auditory cortex. To provide support for this 
claim, we performed the confirmatory grey matter volume comparisons across the four groups within the 
lateral frontotemporal ROIs which were used to extract neurophysiological signals from. We performed 
ANCOVAs to test for group differences whilst accounting for differences in age and TIV. As expected there were 
no significant effect of the group in any of the six ROIs, confirming that the differences we find in the deviant 
responses could not be attributed to local GM atrophy. C: Controls; F: Cognitively frail; MCI: Mild cognitive 
impairment; AD: Alzheimer’s disease. 




Figure 3. Associative and novelty deviant responses by group. A-D. Topoplots show the mean gradiometer 
activity across the scalp for the DA, DN and STD conditions in 100 ms time windows in four groups. Note that 
the DN amplitude is higher after the N100 peak, compared to both DA and STD conditions in control and 
cognitively frail groups. The gradiometer activity in the MCI and Alzheimer’s disease groups are weaker 
compared to the control and cognitively frail groups. E. Plots display the RMS time series for the left hemisphere 
ROIs for simplicity. Dashed vertical lines mark the sound onset. Note that the amplitude differences between 
the deviants and the standard in the frontal regions were larger than the temporal regions, and the deviant 
effects are stronger in the control and cognitively frail groups; and that there is considerably higher variance in 
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the MCI group. See the Extended data for the renderings of the source activity (Figure 3-1). Amp: Amplitude; 
AU: Arbitrary units; DA: Associative deviant; DN: Novelty deviant; fT: Femtotesla; LHG: Left Heschl’s gyrus; LIFG: 
Left inferior frontal gyrus; LSTG: Left superior temporal gyrus; STD: Standard. 
 




Figure 3-1: Source activity: The renderings display mean source activity in 100 ms moving time windows in the 
Control group. In line with the topoplots activity and our RMS findings, here we find the activation of a bilateral 
frontotemporal network peaking at 100 ms. Further compared to the standard condition, deviant conditions 
show stronger and more widespread activity in the frontotemporal regions 200 ms after the sound onset. DA: 
Associative deviant; DN: Novelty deviant: STD: Standard. 




Figure 4. Neurophysiological responses are related to clinical and volumetric differences between individuals. A. 
The t-map displays the general linear model results across predictors and associative and novelty deviant mean 
responses for each region of interest (ROI). The white squares indicate significant effects. Note that the effects 
are stronger for the LHG across the ROIs, and for the novelty deviant compared to the associative deviant.  B. 
The scatterplots display the negative relationship between the associative and novelty deviant means in the 
LHG with the hippocampal GMV across the sample. ACER: Addenbrooke’s Cognitive Examination Revised; ACER 
mem: ACER memory subscale; ENT: Entorhinal grey matter volume; GMV: Grey matter volume; HIP: 
Hippocampal grey matter volume; LHG: L Heschl’s gyrus; LIFG: L inferior frontal gyrus; LSTG: L superior temporal 








Table 1. Demographic and cognitive screening results for the four study populations.  
 Controls Cognitive frail MCI Alzheimer 
Group size (Female) 38 (17 F) 26 (14 F) 15 (4 F) 11 (6 F) 
Age (years) 72.19 ± 8.88 79.98 ± 9.50 75.54 ± 7.60 74.53 ± 11.17 
Education (years) 14.97 ± 3.86 11.07 ± 2.88 16.68 ± 4.99 11.55 ± 3.54 
Hearing left (dB) 51.92 ± 13.32 44.15 ± 16.06 52.88 ± 14.77 54.80 ± 10.01 
Hearing right (dB) 53.55 ± 12.44 43.38 ± 16.35 57.63 ± 9.40 50.00 ± 12.01 
MMSE (/30) 28.34 ± 1.47 26.07 ± 2.28 26.37 ± 2.73 23.20 ± 2.78 
ACE-R (/100) 93.71 ± 3.04 80.92 ± 6.01 83.68 ± 8.41 68.6 ± 8.11 
ACE-R memory (/26) 23.63 ± 1.94 18.38 ± 3.69 16.81 ± 6.09 10.7 ± 3.43 
Training test (/100) 65.78 ± 23.55 50.96 ± 20.59 44.16 ± 24.02 37.50 ± 27.95 
MCI: Symptomatic mild cognitive impairment after secondary/tertiary memory clinic assessment; ACE-R: Revised 
Addenbrooke’s Cognitive Examination; MMSE: Mini Mental State Examination.  See Figure 2B for comparisons 
between groups. 
Table 2. Voxel based morphometry of volume differences between groups. Columns in the table indicate the 
peak cluster, coordinates of the peak in mm, the extent of the cluster, the cluster mass and corrected p-value 
for the cluster respectively. 
Test Cluster peak x, y, z (mm) Cluster extent k pFWE 
Control>MCI R middle temporal 58, -39, 3 R superior temporal,  




26826 < 0.001 
 L middle temporal -52, -54, 12 L fusiform, L inferior, 
L hippocampus, L 
parahippocampal 
24165 < 0.001 
 
 L middle frontal -21, 41, 30 L superior frontal 2063 0.004 
 L precentral -40, 6, 36 L inferior frontal 1407 0.020 
Control>Alzheimer R hippocampus 28, -13, -11 L/R 
parahippocampal, L 
fusiform, L/R 
putamen, L caudate, 
L superior frontal, L 
hippocampus, L 
insula, L medial 
frontal 
55790 < 0.001 
 L middle temporal -57, -16, -9 L inferior temporal, L 
middle temporal 
7744 < 0.001 
 R middle temporal 64, -12, -20 R inferior temporal 4539 < 0.001 
 L postcentral -50, -18, 34 L inferior parietal 1258 0.028 
Cognitively 
frail>MCI 
L inferior temporal -34, 5, -35 L hippocampus, L 
parahippocampal, L 
middle temporal, L 
fusiform 
7546 < 0.001 






L hippocampus -22, -13, -
14 
L parahippocampal, L 
fusiform, L inferior 
temporal 
3723 < 0.001 
k: Cluster mass; pFWE: p-value corrected for family-wise error rate. MCI=symptomatic mild cognitive impairment 
after secondary/tertiary memory clinic assessment 
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Table 3. Regional differences in the response to novelty deviants (DN) and associative deviants (DA) compared 
to standard trials.  
Contrast ROI Group k pcor Time (ms) 
STD-DN LIFG Control -1478.03 < 0.001 31-500 
  Frail -938.79 < 0.001 175-500 
 RIFG Control -1631.81 < 0.001 1-500 
 LSTG Control -715.93 0.002 255-500 
  Frail -449.99 0.021 331-500 
 RSTG Control -1068.44 0.003 172-500 
  Frail -870.95 0.003 197-500 
  Alzheimer -279.53 0.041 391-500 
 LHG Controls -348.23 0.034 355-500 
 RHG Controls -464.34 0.021 305-500 
  Frail -253.10 0.046 380-500 
  MCI -261.62 0.041 350-470 
STD-DA LIFG Control -480.41 0.023 254-500 
  Frail -680.74 0.014 171-497  
  MCI -974.42 0.004 150-500 
 RIFG Control -944.45 < 0.001 192-500 
  Frail -561.03 0.013 188-458 
  Alzheimer -929.57 0.003 162-500 
DA: Associative deviant; DN: Novelty deviant; k: Cluster mass; LHG: L Heschl’s gyrus; LIFG: L inferior frontal gyrus; 
LSTG: L superior temporal gyrus; pcor: Corrected p-value; RHG: R Heschl’s gyrus; RIFG: R inferior frontal gyrus; 
ROI: Regions of interest; RSTG: R superior temporal gyrus; STD: Standard. See the Extended data for the log 
transformed version of this analysis. (Table 3-1). 
 
Table 3-1. Regional differences in the response to novelty deviants (DN) and associative deviants (DA) compared 
to standard trials. In this version of the analysis, we performed the statistical comparisons on the log 
transformed squared RMS time series, to ensure the normality assumption of the GLMs is met. The results of 
the RMS and log transformed RMS time series largely overlap. However in the latter analysis task-group 
interaction effects do not reach statistical significance. k: Cluster mass; pcor: Cluster corrected p-value. 
 
Contrast ROI Group k pcor Time 






  Frail -774,96 0.002 262-500 
 RIFG Control -204.22 0.027 23-90 
   -134.42 0.051 165-222 
   -594.2 0.004 343-500 
 LSTG Control -433.04 0.006 381-500 
  Frail -177.85 0.045 352-428 
   -206.56 0.037 430-500 
 RSTG Control -275.66 0.022 175-274 
   -631.41 0.002 295-500 
  Frail -274.8 0.018 260-380 
   -391.41 0.004 382-500 
  Alzheimer -182.9 0.041 438-500 
 LHG Controls -273.65 0.024 388-500 
 RHG Controls -336.9 0.01 329-487 
  Frail -138.69 0.043 1-48 
STD-DA LIFG MCI -508.9 0.002 214-411 
   -155.91 0.047 454-500 
 RIFG Control -267.28 0.014 211-315 
  Frail -346.16 0.018 305-447 
  Alzheimer -775.37 0.008 177-500 
 
